- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
取扱業務
日本語版をご希望の場合はこちらをご覧ください。
ウェブページを見る日本語 - Japanese
オフィス（国内外拠点）
ニュース＆インサイト
キング＆スポールディング、アジア開発銀行（ADB）官民連携部の前部長を採用
Tokyo Dispute Resolution & Crisis Management Newsletter – November 2018
東京オフィス設立4周年および 紛争解決・危機管理ニュースレター（通算35版リリース）について － 2019年9月号
東京オフィス 紛争解決・危機管理ニュースレター — 2020 年 5 月
東京オフィス 紛争解決・危機管理ニュースレター — 2020 年 6月
東京オフィス 紛争解決・危機管理ニュースレター — 2020 年 7月
東京オフィス 紛争解決・危機管理ニュースレター — 2020 年 8月
東京オフィス 紛争解決・危機管理ニュースレター — 2020 年 10月
Related Lawyers
インサイト
Newsletter
10月 29, 2020
Tokyo Dispute Resolution & Crisis Management Newsletter – October 2020
閉じる
Recognition
Ranked in Chambers Global for Corporate Crime & Investigations since 2016 to present
Two former Deputy Attorneys General
“The premier firm in this practice area.”
U.S. News & World Report/Best Lawyers
Nine former members of DOJ leadership
Ranked in Legal 500 for Corporate Investigations and White-Collar Criminal Defense since 2015 to present.
Six former U.S. Attorneys
“Very strategic… collaborative and politically-savvy.”
Chambers USA
23 former Assistant U.S. Attorneys
“Excellent credibility before the agencies across a broad swathe of white-collar matters.”
Legal 500
44 DOJ alumni
Ranked in Chambers USA for Securities: Regulation (Nationwide) since 2017
Three FINRA alumni
“Ideally placed to take on high-stakes criminal cases and parallel civil litigation.”
Legal 500
13 American College of Trial Lawyers
“Clients are kept out of the public eye” by a team “packed with former federal prosecutors.”
GIR